Astrazeneca plc ADR (NASDAQ:AZN) currently has a daily average trading volume of 5.49M but it saw 4174854 shares traded in last market. With a market cap of 223.97B USD, the company’s current market price of $72.22 came falling about -0.52 while comparing to the previous closing price of $72.60. In past 52 weeks, the stock remained buoying in the range of price level as high as $87.68 and as low as $62.75. In the recent trading on the day, stock has struck highest price mark of $72.05 while lowest mark touched by it was $72.84.
Taking a look at 20-day trading activity of Astrazeneca plc ADR (AZN) gives us an average price of $75.10, while its current price level is -17.63% below from 52-week high level whereas it is 15.09% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $73.76 while that of 200 days or SMA-200 reads an average of $74.60. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.47% during that period while stretching the period over a month that decreases to 1.45%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.63 which implies that the stock is in neutral territory.
Over the week, AZN’s stock price is moving -0.69% down while it is -6.51% when we observe its performance for the past one month. Year-to-date it is 10.23% up and over the past year, the stock is showing an upside performance of 7.39%.
The company is expected to be releasing its next quarterly report on 2025-Feb-05, for which analysts forecasted an EPS of 1.12 while estimate for next year EPS is 4.45. In next quarter, company is expected to be making quarterly sales of $13.97B as analysts are expecting the sales for current fiscal year at $57.26B and seeing the company making $60.76B in sales next year. Moreover, analysts are in estimates of $13.73B for current-quarter revenue.
Currently, Astrazeneca plc ADR’s total number of outstanding shares is 3.10B with 0.00% of that held by the insiders while 17.50% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 10.28% and return on equity (ROE) at 17.60%. It has a price to earnings ratio (P/E ratio) of 32.05 while having a 14.28 of forward P/E ratio. Stock’s beta reads 0.40. Stock has a price to book (P/B) ratio of 5.49 while price to sale or P/S ratio amounts to 4.14. Its return on asset (ROA) is 6.86% on average.
